Bevacizumab: Anti-VEGF monoclonal antibody, avastin, rhumab-VEGF

被引：0
|
作者：
不详
机构：
来源：
Drugs in R & D | 2002年 / 3卷 / 1期
关键词：
Bevacizumab; Irinotecan; Metastatic Breast Cancer; Folinic Acid; Retinal Vein Occlusion;
D O I：
10.2165/00126839-200203010-00006
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：28 / 30
页数：2
相关论文
共 50 条
  • [21] Early antivascular effects of bevacizumab anti-VEGF monoclonal antibody on colorectal carcinomas assessed with functional CT imaging
    Koukourakis, Michael I.
    Mavanis, Ioannis
    Kouklakis, George
    Pitiakoudis, Michael
    Minopoulos, George
    Manolas, Costantinos
    Simopoulos, Costantinos
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (03): : 315 - 318
  • [22] Effects of the Anti-VEGF Monoclonal Antibody Bevacizumab in a Preclinical Model and in Patients With Refractory and Multiple Relapsed Hodgkin Lymphoma
    Reiners, Katrin S.
    Gossmann, Axel
    von Strandmann, Elke Pogge
    Boell, Boris
    Engert, Andreas
    Borchmann, Peter
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (05) : 508 - 512
  • [23] Phase it study of Bevacizumab (anti-VEGF humanized monoclonal antibody) in patients with myelodysplastic syndrome (MDS): Preliminary results
    Gotlib, J
    Jamieson, CHM
    List, A
    Cortes, J
    Albitar, M
    Sridhar, K
    Dugan, K
    Quesada, S
    Diaz, G
    Pate, O
    Novotny, W
    Chen, H
    Greenberg, PL
    BLOOD, 2003, 102 (11) : 425A - 425A
  • [24] Imaging expression of vascular endothelial growth factor (VEGF) in tumors with a radiolabeled anti-VEGF monoclonal antibody
    Boerman, O. C.
    Stollman, T.
    Scheer, M.
    Franssen, G.
    Corstens, F. H. M.
    Ruers, T. J. M.
    Oyen, W. J. G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S191 - S191
  • [25] Imaging expression of vascular endothelial growth factor (VEGF) in tumors with a radiolabeled anti-VEGF monoclonal antibody
    Boerman, O. C.
    Scheer, M.
    Stillebroer, A.
    Stollman, T.
    Leenders, W.
    Oostenwijk, E.
    Ruers, T.
    Mulders, P.
    Oyen, W. J.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2008, 23 (04) : 514 - 515
  • [26] Bevacizumab (Avastin) conjugated microbubbles for anti-VEGF treatment of neovascular age-related macular degeneration
    Zhang, Leilei
    Xu, Jeff
    Huang, Jiwei
    Roberts, Cynthia
    Xu, Ronald
    OPHTHALMIC TECHNOLOGIES XX, 2010, 7550
  • [27] Anti-VEGF bevacizurnab (Avastin) for radiation retinopathy and optic neuropathy
    Finger, P. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S8 - S9
  • [28] VEGF, anti-VEGF and diseases
    Corvol, Pierre
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2008, 192 (02): : 289 - 302
  • [29] Inhibition of Corneal Neovascularization by Topical Bevacizumab (Anti-VEGF) and Sunitinib (Anti-VEGF and Anti-PDGF) in an Animal Model
    Perez-Santonja, Juan J.
    Campos-Mollo, Ezequiel
    Lledo-Riquelme, Mariola
    Javaloy, Jaime
    Alio, Jorge L.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 150 (04) : 519 - 528
  • [30] Biodistribution of humanized anti-VEGF monoclonal antibody/bevacizumab on peritoneal metastatic models with subcutaneous xenograft of gastric cancer in mice
    Yasumichi Yagi
    Sachio Fushida
    Shinichi Harada
    Tomoya Tsukada
    Jun Kinoshita
    Katsunobu Oyama
    Hideto Fujita
    Itasu Ninomiya
    Takashi Fujimura
    Masato Kayahara
    Seigo Kinuya
    Masakazu Yashiro
    Kousei Hirakawa
    Tetsuo Ohta
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 745 - 753
12345